Inactive Instrument

Insiders AEQUUS Other OTC

Equities

CA0076361033

End-of-day quote Other OTC Other stock markets
- ^CAD	-

05-10	Aequus Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-30	Aequus Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Aequus Pharmaceuticals Inc. Announces the Resignation of Stuart Fowler from the Board of Directors	05/04/23	CI
Aequus Pharmaceuticals Inc. Announces Resignation of Jason Flowerday from the Board of Directors	22/04/22	CI
Aequus Pharmaceuticals Inc. Appoints Marc Lustig as a Director	13/02/21	CI
Aequus Pharmaceuticals Inc. Appoints Ann Fehr as Corporate Secretary	09/12/20	CI
Aequus Pharmaceuticals Inc. Announces Resignation of Anne Stevens as Chief Operating Officer	13/11/20	CI
Aequus Pharmaceuticals Inc. Appoints Grant Larsen as Chief Commercial Officer	20/08/20	CI
Aequus Pharmaceuticals Inc. Appoints Stuart Fowler as New Director	19/02/20	CI
Aequus Pharmaceuticals Inc. Announces Executive Changes	03/02/20	CI
Aequus Pharmaceuticals Inc. Announces Board Appointments	15/11/18	CI
Aequus Pharmaceuticals Inc. Appoints Strategic Advisory Board Members	05/11/18	CI
Aequus Pharmaceuticals Inc. Announces Board Changes	13/07/18	CI
Aequus Pharmaceuticals Inc. Appoints Ann Fehr as Chief Financial Officer	21/07/16	CI
Aequus Pharmaceuticals Announces Executive Appointments	16/07/15	CI
Aequus Announces Executive Changes	14/07/15	CI
Aequus Pharmaceuticals Inc. Appoints Hamed Shahbazi as an Independent Director on its Board of Directors	17/03/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer